title: Gastrointestinal: Severe de novo stricture formation following biodegradable esophageal stent.
authors.affiliation: Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia.
authors.forename: M X
authors.initials: MX
authors.lastname: Ma
authors.affiliation: Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia.
authors.forename: Mws
authors.initials: M
authors.lastname: Chin
authors.affiliation: Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Edmunds
authors.affiliation: Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Jennings
mesh_terms: D020341:Absorbable Implants / Q000009:adverse effects*; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy; D004106:Dilatation; D004938:Esophageal Neoplasms / Q000628:therapy*; D000077277:Esophageal Squamous Cell Carcinoma; D004940:Esophageal Stenosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D004945:Esophagoscopy; D005260:Female; D005773:Gastroscopy; D005774:Gastrostomy; D006801:Humans; D011474:Prosthesis Design; D011832:Radiation Injuries / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D012008:Recurrence; D015607:Stents / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome